Argenica Therapeutics Stock Forecast

Buy candidate since Aug 07, 2026 Gain 2.86%

The Argenica Therapeutics Limited stock price gained 2.86% on the last trading day (Tuesday, 11th Aug 2026), rising from A$0.175 to A$0.180. During the last trading day the stock fluctuated 0% from a day low at A$0.180 to a day high of A$0.180. The price has been going up and down for this period, and there has been a 5.88% gain for the last 2 weeks. Volume fell on the last day by -82 thousand shares and in total, 5 thousand shares were bought and sold for approximately A$945.54 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at A$0.189 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 22.01% during the next 3 months and, with a 90% probability hold a price between A$0.131 and A$0.231 at the end of this 3-month period.

AGN.AX Signals & Forecast

The Argenica Therapeutics Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at A$0.163 and A$0.137. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 25, 2026, and so far it has risen 100.00%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Argenica Therapeutics Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at A$0.160 and A$0.150. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Argenica Therapeutics Limited finds support just below today's level at A$0.160. If this is broken, then the next support from accumulated volume will be at A$0.150 and A$0.140.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved A$0 between high and low, or 0%. For the last week the stock has had daily average volatility of 5.75%.

Our recommended stop-loss: A$0.174 (-3.20%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 33 days ago.)

Trading Expectations (AGN.AX) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Argenica Therapeutics Limited to open at A$0.180, and during the day (based on 14 day Average True Range), to move between A$0.174 and A$0.186, which gives a possible trading interval of +/-A$0.0114 (+/-6.57%) up or down from last closing price. If Argenica Therapeutics Limited takes out the full calculated possible swing range there will be an estimated 6.57% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ A$0.160, some A$0.0200 (11.11%) from the current price of A$0.180, our system finds the risk reward attractive.

Is Argenica Therapeutics Limited stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Argenica Therapeutics Limited stock to perform well in the short-term.

Current score: 4.507 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 12, 2026 - A$0.180 ( 0.00000000000002%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk